This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
rsi: Archive
Aehr Test Systems (AEHR) Loses -29.25% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Aehr Test Systems (AEHR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
AEHRPositive Net Change
rsi stock-price-movement
Down -25.93% in 4 Weeks, Here's Why You Should You Buy the Dip in Aehr Test Systems (AEHR)
by Zacks Equity Research
Aehr Test Systems (AEHR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
AEHRPositive Net Change
rsi stock-price-movement
After Plunging -10.13% in 4 Weeks, Here's Why the Trend Might Reverse for Caesars Entertainment (CZR)
by Zacks Equity Research
Caesars Entertainment (CZR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
CZRNegative Net Change
rsi stock-price-movement
Down -8.55% in 4 Weeks, Here's Why You Should You Buy the Dip in Seadrill (SDRL)
by Zacks Equity Research
Seadrill (SDRL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
SDRLNegative Net Change
rsi stock-price-movement
Down -8.51% in 4 Weeks, Here's Why Hanmi Financial (HAFC) Looks Ripe for a Turnaround
by Zacks Equity Research
Hanmi Financial (HAFC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
HAFCPositive Net Change
rsi stock-price-movement
After Plunging -7.47% in 4 Weeks, Here's Why the Trend Might Reverse for VICI Properties Inc. (VICI)
by Zacks Equity Research
The heavy selling pressure might have exhausted for VICI Properties Inc. (VICI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
VICINegative Net Change
rsi stock-price-movement
After Plunging -8.83% in 4 Weeks, Here's Why the Trend Might Reverse for Interactive Brokers Group, Inc. (IBKR)
by Zacks Equity Research
Interactive Brokers Group, Inc. (IBKR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
IBKRPositive Net Change
rsi stock-price-movement
Down -18.58% in 4 Weeks, Here's Why You Should You Buy the Dip in Fastly (FSLY)
by Zacks Equity Research
Fastly (FSLY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
FSLYPositive Net Change
rsi stock-price-movement
After Plunging -16.05% in 4 Weeks, Here's Why the Trend Might Reverse for Lucid Group (LCID)
by Zacks Equity Research
Lucid Group (LCID) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
LCIDPositive Net Change
rsi stock-price-movement
CRA (CRAI) Loses -5.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for CRA (CRAI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
CRAIPositive Net Change
rsi stock-price-movement
Puma Biotech (PBYI) Loses -18.62% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Puma Biotech (PBYI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
PBYIPositive Net Change
rsi stock-price-movement
Kymera Therapeutics, Inc. (KYMR) Loses -33.08% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Kymera Therapeutics, Inc. (KYMR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
KYMRPositive Net Change
rsi stock-price-movement
Down -8.61% in 4 Weeks, Here's Why You Should You Buy the Dip in Ecolab (ECL)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Ecolab (ECL) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
ECLPositive Net Change
rsi stock-price-movement
Down -11.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Terreno (TRNO)
by Zacks Equity Research
Terreno (TRNO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
TRNONegative Net Change
rsi stock-price-movement
After Plunging -14.57% in 4 Weeks, Here's Why the Trend Might Reverse for Badger Meter (BMI)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Badger Meter (BMI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
BMIPositive Net Change
rsi stock-price-movement
Aehr Test Systems (AEHR) Loses -27.26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Aehr Test Systems (AEHR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
AEHRPositive Net Change
rsi stock-price-movement
Down -34.74% in 4 Weeks, Here's Why You Should You Buy the Dip in Vera Therapeutics, Inc. (VERA)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Vera Therapeutics, Inc. (VERA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
VERAPositive Net Change
rsi stock-price-movement
Down -19.41% in 4 Weeks, Here's Why GameStop (GME) Looks Ripe for a Turnaround
by Zacks Equity Research
GameStop (GME) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
GMENegative Net Change
rsi stock-price-movement
Kymera Therapeutics, Inc. (KYMR) Loses -35.95% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Kymera Therapeutics, Inc. (KYMR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
KYMRPositive Net Change
rsi stock-price-movement
Newell Brands (NWL) Loses -25.52% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Newell Brands (NWL) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
NWLNegative Net Change
rsi stock-price-movement
Down -34.9% in 4 Weeks, Here's Why Nurix Therapeutics, Inc. (NRIX) Looks Ripe for a Turnaround
by Zacks Equity Research
Nurix Therapeutics, Inc. (NRIX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
NRIXNegative Net Change
rsi stock-price-movement
Down -20.51% in 4 Weeks, Here's Why Insulet (PODD) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Insulet (PODD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
PODDPositive Net Change
rsi stock-price-movement
ProKidney Corp. (PROK) Loses -54.93% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
ProKidney Corp. (PROK) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
PROKPositive Net Change
rsi stock-price-movement
Down -15.15% in 4 Weeks, Here's Why You Should You Buy the Dip in Badger Meter (BMI)
by Zacks Equity Research
Badger Meter (BMI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
BMIPositive Net Change
rsi stock-price-movement
Down -38.05% in 4 Weeks, Here's Why You Should You Buy the Dip in Vera Therapeutics, Inc. (VERA)
by Zacks Equity Research
Vera Therapeutics, Inc. (VERA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
VERAPositive Net Change
rsi stock-price-movement